Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1856 | Thyroid cancer | ICEECE2012

Papillary carcinoma in a hyperfunctioning thyroid nodule

Peros K. , Zmire J. , Bozek T. , Stakor M. , Babic K.

Introduction: Thyroid hyperfunctioning nodule usually represents benign tumor. Less than 1% of all cases have been reported as malignant lesion, especially in the presence of hyperthyroidism.Case report: An asymptomatic 46-year-old man with a history of diabetes mellitus type 2 came for regular diabetic check. Two palpable thyroid nodules were detected during a routine physical examination. Thyroid function tests showed hyperthyroidism: TSH <0.005 mI...

ea0019p377 | Thyroid | SFEBES2009

Management of maternal hypothyroidism in the joint antenatal endocrine clinic

Thanabalasingham G , Ma K , Allen K , Street P , Elsheikh M

Background: In the first trimester, the foetus is dependent on circulating maternal thyroid hormones for normal brain development. Maintenance of euthyroidism is important throughout pregnancy and maternal hypothyroidism is associated with adverse foetal outcomes.Aim: To audit the management of pregnancies complicated by hypothyroidism in a joint antenatal endocrine clinic in comparison with the UK guidelines from the British Thyroid Association (2006).<...

ea0011p942 | Thyroid | ECE2006

Comparison of radioiodine with radioiodine plus lithium in the treatment of hyperthyroidism

Ahmed K , Nijher GMK , Banerjee A , Frank J , Meeran K

Introduction: Radioactive Iodine (RAI) is a well-established and effective treatment for hyperthyroidism. Lithium (Li) blocks the release of organic iodide and thyroid hormone from the thyroid gland without effecting thyroidal RAI uptake. Through decreasing the loss of RAI from the thyroid it has also been shown to reduce urinary RAI excretion. Its use as an adjunct to RAI in the therapy of hyperthyroidism has been postulated, but information on the subject is limited.<p c...

ea0010p61 | Pituitary | SFE2005

Reproducibility of the growth hormone response to resistance exercise in humans

Gilbert K , Thompson D , Hall G , Stokes K

ObjectiveThere is large inter-individual variation in the growth hormone (GH) response to resistance exercise, but the intra-individual variation is unknown. This study aimed to determine the reproducibility of the GH response to a 30-min resistance exercise session.DesignFollowing local Ethics Committee approval, nine male participants were familiarised before completing three trials in a random order. Durin...

ea0010p62 | Pituitary | SFE2005

Growth hormone and ghrelin responses to very intense exercise in humans

Stokes K , Sykes D , Gilbert K , Frystyk J

ObjectiveIt has been suggested that ghrelin may play a role in regulating the growth hormone (GH) response to exercise. This study was designed to determine whether very intense exercise alters circulating ghrelin concentrations. Design: Following Local Ethics Committee approval, 7 male volunteers were familiarised before completing two trials in a random order. In one trial participants performed a single 30-s sprint on a cycle ergometer, in the ...

ea0010p96 | Thyroid | SFE2005

Comparison of radioiodine with radioiodine plus lithium in the treatment of hyperthyroidism

Ahmed K , Nijher G , Bannerjee A , Frank J , Meeran K

Introduction: Radioactive Iodine (RAI) is a well-established and effective treatment for hyperthyroidism. Lithium (Li) blocks the release of organic iodide and thyroid hormone from the thyroid gland without effecting thyroidal RAI uptake. Through decreasing the loss of RAI from the thyroid it has also been shown to reduce urinary RAI excretion. Its use as an adjunct to RAI in the therapy of hyperthyroidism has been postulated, but information on the subject is limited....

ea0009p33 | Diabetes and metabolism | BES2005

Testosterone does not promote A7r5 rat aortic vascular smooth muscle cell growth

Kerry K , Jones R , Channer K , Jones T

Vascular smooth muscle cells (VSMC) form a major constituent of the atherosclerotic plaque providing structural stability. However, increased cell number due to high proliferation rates can lead to greater artery occlusion. Testosterone replacement therapy improves exercise capacity and reduces symptoms of angina in men with coronary artery disease, although its effect upon VSMC growth is currently unknown. Testosterone deficiency is associated with increased atheroma burden a...

ea0009p35 | Diabetes and metabolism | BES2005

Study of the effect of testosterone upon apoptosis in the rat aortic A7r5 vascular smooth muscle cell line

Kerry K , Jones R , Channer K , Jones T

Several studies have demonstrated that atherosclerosis is associated with low serum levels of testosterone and replacement therapy reduces myocardial ischaemia in men. Vascular smooth muscle cell (VSMC) apoptosis reduces plaque stability. The role of testosterone if any, in this process is unknown. Testosterone has been demonstrated act via both the classic androgen receptor and by calcium channel antagonism. Calcium channel blockers have been shown to induce VSMC apoptosis. W...

ea0009p84 | Endocrine tumours and neoplasia | BES2005

DNA array analysis of a vitamin D-resistant variant of MCF-7 breast cancer cells

Townsend K , Colston K , Bujalska I , Campbell M , Hewison M

The active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25D3) is a potent antiproliferative agent with putative applications in the treatment of common cancers. However, doses of 1,25D3 required to achieve tangible anticancer responses also stimulate unwanted calciotropic effects. Data suggest that this is due, in part, to acquired resistance to 1,25D3 in cancer cells, particularly in more aggressive tumours. To investigate this fu...

ea0009p223 | Clinical | BES2005

Effect of timing of prolactin sampling on the incidence of spurious hyperprolactinaemia

Lewandowski K , Skowronska-Jozwiak E , Szosland K , Lewinski A

It is recognized that a substantial proportion of patients found to have raised prolactin (PRL) level on a single testing is subsequently found to have normal PRL levels. Though this is often attributed to stress or medication factor, it should be noted, that PRL secretion displays diurnal variation with a nocturnal peak in the late-night/early morning hours. In our study we tested the hypothesis, that in some patients raised PRL levels in the morning may reflect individual di...